Jing Sun

Dr. Jing Sun

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 December 2021 in JAMA Internal Medicine
Verified
Journal Article
Open access
PDF file
JSJing Sun
Jing Sun
QZQulu Zheng
Qulu Zheng
VMVithal Madhira
Vithal Madhira
AOAmy L. Olex
Amy L. Olex
AAAlfred J. Anzalone
Alfred J. Anzalone
ECElizabeth A. Chirischilles
Elizabeth A. Chirischilles
Vaccines against SARS-CoV-2 have been found to be highly effective and safe in both clinical trials and real-world settings.1-7 Breakthrough infection, which is defined as COVID-19 infection after an individual has completed all required doses of a SARS-CoV-2 vaccine with a typical 14-day lag period, is rare in the general population.5,6,8 In the US, 22 115 breakthrough infection cases were reported to the Centers for Disease Control and Prevention (CDC) after approximately 183 million persons received full vaccination by September 27, 2021.9,10 However, because most of the breakthrough cases were asymptomatic or had mild disease,9 surveillance data likely reflect underreported cases.

18 November 2022 in Cancer Discovery
Verified
Journal Article
Open access
PDF file
ZFZachariah H. Foda
Zachariah H. Foda
AAAkshaya V. Annapragada
Akshaya V. Annapragada
KBKavya Boyapati
Kavya Boyapati
DBDaniel C. Bruhm
Daniel C. Bruhm
NVNicholas A. Vulpescu
Nicholas A. Vulpescu
VVVictor E. Velculescu
Victor E. Velculescu
Liver cancer is a major cause of cancer mortality worldwide. Screening individuals at high risk, including those with cirrhosis and viral hepatitis, provides an avenue for improved survival, but current screening methods are inadequate. In this study, we used whole-genome cell-free DNA (cfDNA) fragmentome analyses to evaluate 724 individuals from the United States, the European Union, or Hong Kong with hepatocellular carcinoma (HCC) or who were at average or high-risk for HCC. Using a machine learning model that incorporated multifeature fragmentome data, the sensitivity for detecting cancer was 88% in an average-risk population at 98% specificity and 85% among high-risk individuals at 80% specificity. We validated these results in an independent population. cfDNA fragmentation changes reflected genomic and chromatin changes in liver cancer, including from transcription factor binding sites. These findings provide a biological basis for changes in cfDNA fragmentation in patients with liver cancer and provide an accessible approach for noninvasive cancer detection. Significance: There is a great need for accessible and sensitive screening approaches for HCC worldwide. We have developed an approach for examining genome-wide cfDNA fragmentation features to provide a high-performing and cost-effective approach for liver cancer detection. See related commentary Rolfo and Russo, p. 532. This article is highlighted in the In This Issue feature, p. 517

1 December 2017 in American Journal of Preventive Medicine
Verified
Journal Article
Open access
JSJing Sun
Jing Sun
FPFalguni Patel
Falguni Patel
RRRuth Rose-Jacobs
Ruth Rose-Jacobs
DFDeborah A. Frank
Deborah A. Frank
MBMaureen M. Black
Maureen M. Black
MCMariana Chilton
Mariana Chilton
This study examined how mothers' Adverse Childhood Experiences (ACEs) relate to their children's developmental risk and assessed how the association is mediated through mothers' depressive symptoms and fair/poor health. Mothers of children aged between 4 months and 4 years were recruited from the emergency department of a children's hospital between March 2012 and June 2015 and interviewed about ACEs, mothers' depressive symptoms and health status, and children's developmental risk (screened via Parents' Evaluations of Developmental Status [PEDS]). Between August and November 2016 a Cochran-Armitage test assessed trend of PEDS by ACEs. Multinomial regression models examined differences in PEDS by ACEs severity. Mediation by mothers' depressive symptoms and self-rated health was also assessed. Of 1,293 mothers, 56.7% reported one or more ACEs. Mothers also reported developmental risk (20.4% overall): 120 (9.2%) reported one concern and 144 (11.2%) reported two or more concerns on the PEDS. Mothers who reported household substance use, mental illness, or an incarcerated household member during childhood were more likely to report at least one child developmental concern on the PEDS. After controlling for covariates, odds of one PEDS concern were 1.86 (95% CI=1.16, 3.00) for ACEs, one to three versus none, and 2.21 (95% CI=1.26, 3.87) for ACEs four or more versus none. Adjusted odds of two or more concerns were 1.70 (95% CI=1.07, 2.72) for ACEs, one to three versus none, and 1.76 (95% CI=1.02, 3.05) for ACEs, four or more versus none. Mothers' depressive symptoms and self-rated health were potential mediators. Mothers' ACEs are significantly associated with their children's developmental risk. If replicated, findings suggest that addressing intergenerational trauma through focus on childhood adversity among young children's caregivers may promote child development.

16 March 2022 in JNCI: Journal of the National Cancer Institute
Verified
Journal Article
Open access
PDF file
JCJessica L Castilho
Jessica L Castilho
ABAihua Bian
Aihua Bian
CJCathy A Jenkins
Cathy A Jenkins
BSBryan E Shepherd
Bryan E Shepherd
KSKeith Sigel
Keith Sigel
T(the North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) of the International Epidemiology Databases to Evaluate AIDS (IeDEA)
the North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) of the International Epidemiology Databases to Evaluate AIDS (IeDEA)
Independent of CD4 cell count, a low CD4/CD8 ratio in people with HIV (PWH) is associated with deleterious immune senescence, activation, and inflammation, which may contribute to carcinogenesis and excess cancer risk. We examined whether low CD4/CD8 ratios predicted cancer among PWH in the United States and Canada. We examined all cancer-free PWH with 1 or more CD4/CD8 values from North American AIDS Cohort Collaboration on Research and Design observational cohorts with validated cancer diagnoses between 1998 and 2016. We evaluated the association between time-lagged CD4/CD8 ratio and risk of specific cancers in multivariable, time-updated Cox proportional hazard models using restricted cubic spines. Models were adjusted for age, sex, race and ethnicity, hepatitis C virus, and time-updated CD4 cell count, HIV RNA, and history of AIDS-defining illness. Among 83 893 PWH, there were 5628 incident cancers, including lung cancer (n = 755), Kaposi sarcoma (n = 501), non-Hodgkin lymphoma (n = 497), and anal cancer (n = 439). The median age at cohort entry was 43 years. The overall median 6-month lagged CD4/CD8 ratio was 0.52 (interquartile range = 0.30-0.82). Compared with a 6-month lagged CD4/CD8 of 0.80, a CD4/CD8 of 0.30 was associated with increased risk of any incident cancer (adjusted hazard ratio = 1.24 [95% confidence interval = 1.14 to 1.35]). The CD4/CD8 ratio was also inversely associated with non-Hodgkin lymphoma, Kaposi sarcoma, lung cancer, anal cancer, and colorectal cancer in adjusted analyses (all 2-sided P < .05). Results were similar using 12-, 18-, and 24-month lagged CD4/CD8 values. A low CD4/CD8 ratio up to 24 months before cancer diagnosis was independently associated with increased cancer risk in PWH and may serve as a clinical biomarker.

22 June 2021 in Hepatology
Verified
Journal Article
Closed access
HKH. Nina Kim
H. Nina Kim
CNCraig W. Newcomb
Craig W. Newcomb
DCDean M. Carbonari
Dean M. Carbonari
JRJason A. Roy
Jason A. Roy
JTJessie Torgersen
Jessie Torgersen
VRVincent Lo Re
Vincent Lo Re

2 August 2021 in Addiction
Verified
Journal Article
Closed access
PDF file
JSJing Sun
Jing Sun
SMShruti H. Mehta
Shruti H. Mehta
JAJacquie Astemborski
Jacquie Astemborski
DPDamani A. Piggott
Damani A. Piggott
BGBecky L. Genberg
Becky L. Genberg
GKGregory D. Kirk
Gregory D. Kirk